Spots Global Cancer Trial Database for scrt
Every month we try and update this database with for scrt cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Total Neoadjuvant Therapy of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer (ENSEMBLE) | NCT05646511 | Locally Advance... | SCRT CAPOX CAPOXIRI | 18 Years - | National Cancer Center Hospital East | |
A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI Status | NCT05669092 | Toripalimab Radiation | Toripalimab CRT SCRT XELIRI FOLFRINOX | 18 Years - 70 Years | Zhejiang Cancer Hospital | |
The First-line Treatment of RCLM With RAS Mutation Was Local Short-course Radiotherapy (SCRT) + PD-1+ Standard Therapy | NCT05640726 | Rectal Cancer | PD-1 SCRT Bevacizumab Oxaliplatin Calcium folinat... 5-fluorouracil | 18 Years - 75 Years | Fujian Cancer Hospital | |
The First-line Treatment of RCLM With RAS Mutation Was Local Short-course Radiotherapy (SCRT) + PD-1+ Standard Therapy | NCT05640726 | Rectal Cancer | PD-1 SCRT Bevacizumab Oxaliplatin Calcium folinat... 5-fluorouracil | 18 Years - 75 Years | Fujian Cancer Hospital | |
A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI Status | NCT05669092 | Toripalimab Radiation | Toripalimab CRT SCRT XELIRI FOLFRINOX | 18 Years - 70 Years | Zhejiang Cancer Hospital |